Creation of the Clearcovid Clinical Research working group

A specific working group for clinical research is now in place and reports directly to the COVID-19 Task Force in order to avoid risk of non compliance. Its purpose is to register, provide advice and support (legal, ethical, regulatory) to all the projects on COVID19  using or re-using human samples and/or personal data and/or implementing clinical studies (social sciences and medical sciences).

This new group includes members of the legal department, ethics units, CRT clinical core, a member of IcareB and the data protection officer. You can contact the Covid Clinical Research working group at : clearcovid_rc@pasteur.fr  for projects that have not yet started.

For those who have already initiated a project, the PI will shortly receive a small questionnaire for you to complete in order for the Covid Clinical Research working group to register and support the COVID 19 projects already initiated.

Projects that are submitted to the open COVID-19 call-for-projects and include the use of patient samples will be systematically evaluated by the Covid Clinical Research working group